Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 39

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 39
---
 indemnified parties under the Divestiture Agreement for losses under the Divestiture Agreement is (1) the recovery of 50% of the amount of such losses from Aadi until the indemnified parties under the Divestiture Agreement have recovered from Aadi with respect to indemnification claims an amount equal to 50% of retention amount, which is equal to $600,000 (the “Retention Amount”), and (2) resorting to the insurance coverage under the RWI Policy. Any indemnification for losses under the Divestiture Agreement will be net of the amount of any insurance proceeds actually received by the applicable indemnified party with respect to such losses, reduced by the amount of any increase in premium or other expense incurred by such indemnified party in connection with or resulting from pursuing or obtaining such insurance proceeds. Kaken has also agreed to not make any amendment, modification, revision or waiver of any provision of the RWI Policy that would materially and adversely impact or affect Aadi without Aadi’s prior written consent. Without limiting any rights of Kaken or the other indemnified parties under the RWI Policy, no indemnified party under the Divestiture Agreement is entitled to be indemnified for any punitive damages under the Divestiture Agreement except to the extent that such indemnified party will be or has become obligated to pay such punitive damages to any other person. Aadi’s indemnification obligations are subject to certain limitations, including a cap equal to $5,000,000 for losses relating to any inaccuracy in or breach of any representation or warranty or losses relating to certain policy exclusions under the RWI Policy.

- 26 -

For more information, please see the section of this proxy statement entitled “The Divestiture Agreement—Indemnification.”

Interests of Aadi’s Directors and Executive Officers in the Divestiture(see page
[●])

When considering the recommendation of Aadi’s board of directors that you vote to approve the Divestiture Proposal, you should be aware
that our directors and executive officers may have interests in the Divestiture that are different from, or in addition to, the interests of our stockholders.

Voting and Support Agreements

In connection with
entering into the Divestiture Agreement, on December 19, 2024, following approval by Aadi’s board of directors, the directors and executive officers of Aadi, as well as certain of their affiliated entities, in each case solely in their
capacities as stockholders of Aadi,